The term IBD is usually used for referring to a group of inflammatory gastro-intestinal
diseases (mainly Crohn's disease and ulcerative colitis). Accordingly, IBD arises as a result …

Background Fecal calprotectin (FC) is a non‐invasive marker of gut inflammation which is
frequently used to guide therapeutic decisions in patients with inflammatory bowel diseases …

2. Methods This document represents the third version of the European Consensus on
reproduction in IBD. The development of this Consensus included the formulation of …

Background & Aims The effect of pregnancy on inflammatory bowel disease (IBD) remains
poorly understood. We aimed to monitor intestinal inflammation using fecal calprotectin (FC) …

The number of patients with inflammatory bowel disease (IBD) is increasing worldwide.
Endoscopy is the gold standard to assess the condition of IBD. The problem with this …

Abstract Background and Aims Inflammatory bowel disease [IBD] affects women during their
childbearing years. Gastrointestinal ultrasonography [GIUS] accurately identifies disease …

Abstract Background and Aims Faecal calprotectin [FC] is a valid and non-invasive marker of
mucosal inflammation. It is widely used both in clinical trials and in daily clinical practice for …

PHYSIOLOGY DURING PREGNANCY Physiologic changes of pregnancy, including uterine
expansion and anatomic compression, and the use of prenatal vitamins may precipitate …

Inflammatory bowel disease (IBD) affects patients during their peak reproductive years. This
raises important questions, in both patients and healthcare providers, regarding conception …

Active inflammatory bowel disease (IBD) may increase the risk of adverse outcomes during
pregnancy. Our aim was to systematically review the role of noninvasive fecal tests, such as …